RXST
RxSight, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +30.0% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -7 | 30.76M | $148.37M | +3 | −9 |
| Q1 2026 | 78 | +10 | 29.02M | $178.70M | +11 | −1 |
| Q4 2025 | 68 | 0 | 28.07M | $292.47M | +1 | −1 |
| Q3 2025 | 17 | 0 | 14.88M | $133.76M | +1 | −1 |
| Q2 2025 | 14 | 0 | 12.67M | $164.75M | +1 | −1 |
| Q1 2025 | 11 | -1 | 4.08M | $103.15M | n/a | −1 |
| Q4 2024 | 12 | 0 | 5.10M | $175.38M | n/a | n/a |
| Q3 2024 | 11 | -1 | 3.15M | $155.64M | n/a | −1 |
| Q2 2024 | 12 | n/a | 2.73M | $164.29M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 3.01M | n/a | $39.09M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (passive) | 2.28M | n/a | $29.62M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | D. E. Shaw & Co. ✦ | 1.32M | +5906.1% | $17.18M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 4 | Citadel Advisors ✦ | 1.03M | +346.5% | $13.36M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 951.18K | +5.9% | $12.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passive) | 916.22K | +1.9% | $11.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 862.67K | -0.1% | $11.22M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 727.95K | New | $9.46M | 0.0% | New | 1 | SEC ↗ ×4 |
| 9 | Baillie Gifford ✦ | 468.94K | +19.6% | $6.10M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 10 | Two Sigma Investments ✦ | 440.46K | +270.5% | $5.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 426.40K | -5.6% | $5.54M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 157.14K | n/a | $2.04M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | AQR Capital Management ✦ | 64.30K | +67.8% | $835,900 | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 14 | T. Rowe Price ✦ | 23.10K | +30.2% | $301,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $9.46M | 0.0% |
Exited
| Point72 Asset Management | $3.89M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 162 holders, 37.72M shares, $223.80M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.04K sh · $14,205
Officer · 5.10K sh · $35,496
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology